Intravenous immunoglobulin in symptomatic and asymptomatic children with perinatal HIV infection

L Olopoenia1, M Young, D White

  • 1Department of Pediatrics, DC General Hospital, Washington, DC 20012, USA.

Insights

Intravenous immunoglobulin (IVIG) therapy reduced bacterial infections and improved growth in children with HIV. Symptomatic patients showed greater benefits from this immune support.

Area of Science:

  • Pediatrics
  • Immunology
  • Infectious Diseases

Background:

  • Children born to HIV-infected mothers are at risk for opportunistic infections.
  • Assessing immune support strategies is crucial for managing pediatric HIV.
  • Intravenous immunoglobulin (IVIG) is a potential therapeutic option.

Purpose of the Study:

  • To evaluate the efficacy of monthly IVIG in reducing bacterial infections and improving growth in children with HIV.
  • To compare outcomes between symptomatic, asymptomatic, and indeterminate HIV-infected children receiving IVIG.

Main Methods:

  • A randomized study involving 135 infants born to HIV-infected mothers.
  • Participants received monthly IVIG (200 mg/kg) for one year.
  • Children were categorized into symptomatic (P2), asymptomatic (P1), and indeterminate (PO) groups based on infection evidence.

Main Results:

  • A significant reduction in bacterial infections (otitis media, respiratory, urinary tract, gastroenteritis) was observed in symptomatic (P2) children compared to asymptomatic (P1) and control (PO) groups.
  • Improved growth (weight and height > 50th percentile) was noted in the symptomatic group versus other groups.
  • No significant difference in head circumference was found across the groups.

Conclusions:

  • Monthly IVIG infusions appear beneficial for both symptomatic and asymptomatic HIV-infected children, reducing bacterial infection frequency.
  • Symptomatic HIV-infected children demonstrated a more robust response to IVIG therapy compared to asymptomatic children.
  • IVIG may enhance immune response and support growth in pediatric HIV patients.

Related Concept Videos

Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Poliomyelitis01:17

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...